Legal Representation
Attorney
Brian Focarino
USPTO Deadlines
Next Deadline
49 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
October 17, 2025
Extension Available
Until October 17, 2024
Application History
26 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 5, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 4, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Apr 4, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Apr 4, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 25, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Sep 25, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Sep 25, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Sep 25, 2024 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Sep 25, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Sep 25, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Sep 25, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Sep 25, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 25, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Sep 25, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 13, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 12, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 12, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 12, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 17, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 22, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 22, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 2, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 18, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 18, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 9, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 8, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Pharmaceutical research and development in the field of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders; providing medical and scientific research and medical and scientific research information in the fields of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders; compiling data for research purposes in the fields of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders
Classification
International Classes
042